311 related articles for article (PubMed ID: 29215573)
1. The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.
Zabielska-Koczywąs K; Lechowski R
Molecules; 2017 Dec; 22(12):. PubMed ID: 29215573
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer.
Allen TM; Cheng WW; Hare JI; Laginha KM
Anticancer Agents Med Chem; 2006 Nov; 6(6):513-23. PubMed ID: 17100556
[TBL] [Abstract][Full Text] [Related]
3. Liposome-encapsulated chemotherapy: Current evidence for its use in companion animals.
Børresen B; Hansen AE; Kjaer A; Andresen TL; Kristensen AT
Vet Comp Oncol; 2018 Mar; 16(1):E1-E15. PubMed ID: 29027350
[TBL] [Abstract][Full Text] [Related]
4. New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy.
Gabizon AA; Patil Y; La-Beck NM
Drug Resist Updat; 2016 Nov; 29():90-106. PubMed ID: 27912846
[TBL] [Abstract][Full Text] [Related]
5. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
6. The role of clinical trials in veterinary oncology.
Burton J; Khanna C
Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers.
Yamaguchi K; Matsumoto Y; Suzuki R; Nishida H; Omata D; Inaba H; Kukita A; Tanikawa M; Sone K; Oda K; Osuga Y; Maruyama K; Fujii T
Cancer Sci; 2021 Jun; 112(6):2493-2503. PubMed ID: 33793049
[TBL] [Abstract][Full Text] [Related]
8. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes.
Tahover E; Patil YP; Gabizon AA
Anticancer Drugs; 2015 Mar; 26(3):241-58. PubMed ID: 25415656
[TBL] [Abstract][Full Text] [Related]
9. Advances in nano-delivery systems for doxorubicin: an updated insight.
Kanwal U; Irfan Bukhari N; Ovais M; Abass N; Hussain K; Raza A
J Drug Target; 2018 Apr; 26(4):296-310. PubMed ID: 28906159
[TBL] [Abstract][Full Text] [Related]
10. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
Arabi L; Badiee A; Mosaffa F; Jaafari MR
J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastasis.
Jeglum KA
Vet Clin North Am Small Anim Pract; 1985 May; 15(3):659-66. PubMed ID: 3874470
[No Abstract] [Full Text] [Related]
12. Preclinical models in electrochemotherapy: the role of veterinary patients.
Spugnini EP; Fanciulli M; Citro G; Baldi A
Future Oncol; 2012 Jul; 8(7):829-37. PubMed ID: 22830403
[TBL] [Abstract][Full Text] [Related]
13. Electrochemotherapy in Veterinary Oncology: State-of-the-Art and Perspectives.
Spugnini EP; Baldi A
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):967-979. PubMed ID: 31176458
[TBL] [Abstract][Full Text] [Related]
14. Practical aspects in size and morphology characterization of drug-loaded nano-liposomes.
Peretz Damari S; Shamrakov D; Varenik M; Koren E; Nativ-Roth E; Barenholz Y; Regev O
Int J Pharm; 2018 Aug; 547(1-2):648-655. PubMed ID: 29913218
[TBL] [Abstract][Full Text] [Related]
15. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
16. Intracellular PK/PD Relationships of Free and Liposomal Doxorubicin: Quantitative Analyses and PK/PD Modeling.
Soininen SK; Vellonen KS; Heikkinen AT; Auriola S; Ranta VP; Urtti A; Ruponen M
Mol Pharm; 2016 Apr; 13(4):1358-65. PubMed ID: 26950248
[TBL] [Abstract][Full Text] [Related]
17. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
18. Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs.
Suzuki T; Ichihara M; Hyodo K; Yamamoto E; Ishida T; Kiwada H; Ishihara H; Kikuchi H
Int J Pharm; 2012 Oct; 436(1-2):636-43. PubMed ID: 22850293
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.
Gabizon A; Shmeeda H; Barenholz Y
Clin Pharmacokinet; 2003; 42(5):419-36. PubMed ID: 12739982
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of benzaldehyde in pets with solid tumors: preliminary study.
Grier RL; Merkley DF; Roth JA; Mouw MA
Am J Vet Res; 1982 Dec; 43(12):2270-1. PubMed ID: 6762121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
